The role of orexins/hypocretins in alcohol use and abuse: An appetitive-reward relationship

Frontiers in Behavioral Neuroscience

Volumn , Issue OCTOBER 2012, 2012, Pages

  Kim, Andrezza Kyunmi ^a,b   Brown, Robyn M ^a   Lawrence, Andrew J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alcohol; Drug seeking; Ethanol; Hypocretin; Orexin; Relapse; Reward seeking behavior

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; NEUROPEPTIDE S; OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN A; OREXIN B;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; APPETITE; ASSOCIATION; BEHAVIOR THERAPY; BRAIN ELECTROPHYSIOLOGY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; HUMAN; HYPOTHALAMUS; INSTRUMENTAL CONDITIONING; LOCOMOTION; MOTOR PERFORMANCE; NONHUMAN; PLACE PREFERENCE; PREFRONTAL CORTEX; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REINFORCEMENT; RELAPSE; REVIEW; REWARD; SLEEP WAKING CYCLE;

EID: 84869045342     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2012.00078     Document Type: Review

References (111)

1. Allen, G. V., and Cechetto, D. F. (1992). Functional and anatomical organization of cardiovascular pressor and depressor sites in the lateral hypothalamic area: I. Descending projections. J Comp Neurol 315 (3):313-332.
2. Aston-Jones, G., Smith, R. J., Moorman, D. E., and Richardson, K. A. (2009). Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl 1:112-121.
3. Balcita Pedicino, J., and Sesack, S. (2007). Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. Journal of comparative neurology 503 (5):668-684.
4. Barson, J., Fagan, S., Chang, G.-Q., and Leibowitz, S. (2012). Neurochemical Heterogeneity of Rats Predicted by Different Measures to be High Ethanol Consumers. Alcoholism: clinical and experimental research.
5. Bayerlein, K., Kraus, T., Leinonen, I., Pilniok, D., Rotter, A., Hofner, B., Schwitulla, J., Sperling, W., Kornhuber, J., and Biermann, T. (2011). Orexin A expression and promoter methylation in patients with alcohol dependence comparing acute and protracted withdrawal. Alcohol 45 (6):541-547.
6. Bergman, J. M., Roecker, A. J., Mercer, S. P., Bednar, R. A., Reiss, D. R., Ransom, R. W., Meacham Harrell, C., Pettibone, D. J., Lemaire, W., Murphy, K. L., Li, C., Prueksaritanont, T., Winrow, C. J., Renger, J. J., Koblan, K. S., Hartman, G. D., and Coleman, P. J. (2008). Proline bis-amides as potent dual orexin receptor antagonists. Bioorg Med Chem Lett 18 (4):1425-1430.
7. Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., and Bonci, A. (2006). Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (4):589-601.
8. Borgland, S. L., Storm, E., and Bonci, A. (2008). Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons. Eur J Neurosci 28 (8):1545-1556.
9. Borgland, S. L., Chang, S. J., Bowers, M. S., Thompson, J. L., Vittoz, N., Floresco, S. B., Chou, J., Chen, B. T., and Bonci, A. (2009). Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 29 (36):11215-11225.
10. Boss, C., Brisbare-Roch, C., and Jenck, F. (2009). Biomedical application of orexin/hypocretin receptor ligands in neuroscience. J Med Chem 52 (4):891-903.
11. Bourgin, P., Huitron-Resendiz, S., Spier, A. D., Fabre, V., Morte, B., Criado, J. R., Sutcliffe, J. G., Henriksen, S. J., and De Lecea, L. (2000). Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20 (20):7760-7765.
12. Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., and De Lecea, L. (2005). Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102 (52):19168-19173.
13. Brisbare-Roch, C., Dingemanse, J., Koberstein, R., Hoever, P., Aissaoui, H., Flores, S., Mueller, C., Nayler, O., Van Gerven, J., De Haas, S. L., Hess, P., Qiu, C., Buchmann, S., Scherz, M., Weller, T., Fischli, W., Clozel, M., and Jenck, F. (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13 (2):150-155.
14. Broberger, C., De Lecea, L., Sutcliffe, J. G., and Hokfelt, T. (1998). Hypocretin/orexin-and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402 (4):460-474.
15. Brown, R. E., Sergeeva, O., Eriksson, K. S., and Haas, H. L. (2001). Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40 (3):457-459.
16. Brown, R. E., Sergeeva, O. A., Eriksson, K. S., and Haas, H. L. (2002). Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 22 (20):8850-8859.
17. Burlet, S., Tyler, C. J., and Leonard, C. S. (2002). Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22 (7):2862-2872.
18. Cannella, N., Economidou, D., Kallupi, M., Stopponi, S., Heilig, M., Massi, M., and Ciccocioppo, R. (2009). Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 34 (9):2125-2134.
19. Cason, A. M., Smith, R. J., Tahsili-Fahadan, P., Moorman, D. E., Sartor, G. C., and Aston-Jones, G. (2010). Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 100 (5):419-428.
20. Chang, G. Q., Karatayev, O., Liang, S. C., Barson, J. R., and Leibowitz, S. F. (2012). Prenatal ethanol exposure stimulates neurogenesis in hypothalamic and limbic peptide systems: Possible mechanism for offspring ethanol overconsumption. Neuroscience.
21. Chen, Y. W., Barson, J. R., Chen, A., Hoebel, B. G., and Leibowitz, S. F. (2012). Glutamatergic Input to the Lateral Hypothalamus Stimulates Ethanol Intake: Role of Orexin and Melanin-Concentrating Hormone. Alcohol Clin Exp Res.
22. Clegg, D.J., Air, E.L., Woods, S.C. and Seeley, R.J. (2002) Eating elicited by orexin-A, but not melanin-concentrating hormone, is opioid mediated. Endocrinology 143(8):2995-3000
23. Cox, C. D., Mcgaughey, G. B., Bogusky, M. J., Whitman, D. B., Ball, R. G., Winrow, C. J., Renger, J. J., and Coleman, P. J. (2009). Conformational analysis of N,Ndisubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding. Bioorg Med Chem Lett 19 (11):2997-3001.
24. Date, Y., Ueta, Y., Yamashita, H., Yamaguchi, H., Matsukura, S., Kangawa, K., Sakurai, T., Yanagisawa, M., and Nakazato, M. (1999). Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 96 (2):748-753.
25. Davis, W. M., and Smith, S. G. (1976). Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pavlov J Biol Sci 11 (4):222-236.
26. Dayas, C. V., Mcgranahan, T. M., Martin-Fardon, R., and Weiss, F. (2008). Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biol Psychiatry 63 (2):152-157.
27. De Lecea, L., Kilduff, T. S., Peyron, C., Gao, X., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L., Gautvik, V. T., Bartlett, F. S., 2nd, Frankel, W. N., Van Den Pol, A. N., Bloom, F. E., Gautvik, K. M., and Sutcliffe, J. G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95 (1):322-327.
28. De Wit, H., and Stewart, J. (1981). Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75 (2):134-143.
29. Dess, N.K., Badia-Elder, N.E., Thiele, T.E., Kiefer, S.W. and Blizard, D.A. (1998) Ethanol consumption in rats selectively bred for differential saccharin intake. Alcohol 16(4):275-278.
30. Dhaher, R., Hauser, S. R., Getachew, B., Bell, R. L., Mcbride, W. J., Mckinzie, D. L., and Rodd, Z. A. (2010). The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats. J Addict Med 4 (3):153-159.
31. Di Chiara, G., and Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (14):5274-5278.
32. Di Chiara, G. (2002). From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'. Behavioural pharmacology 13 (5-6):371-377.
33. Dugovic, C., Shelton, J. E., Aluisio, L. E., Fraser, I. C., Jiang, X., Sutton, S. W., Bonaventure, P., Yun, S., Li, X., Lord, B., Dvorak, C. A., Carruthers, N. I., and Lovenberg, T. W. (2009). Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 330 (1):142-151.
34. Elias, C. F., Saper, C. B., Maratos-Flier, E., Tritos, N. A., Lee, C., Kelly, J., Tatro, J. B., Hoffman, G. E., Ollmann, M. M., Barsh, G. S., Sakurai, T., Yanagisawa, M., and Elmquist, J. K. (1998). Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402 (4):442-459.
35. Fadel, J., and Deutch, A. Y. (2002). Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111 (2):379-387.
36. Fuchs, R. A., Evans, K. A., Ledford, C. C., Parker, M. P., Case, J. M., Mehta, R. H., and See, R. E. (2005). The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 30 (2):296-309.
37. Fuchs, R. A., Eaddy, J. L., Su, Z. I., and Bell, G. H. (2007). Interactions of the basolateral amygdala with the dorsal hippocampus and dorsomedial prefrontal cortex regulate drug context-induced reinstatement of cocaine-seeking in rats. Eur J Neurosci 26 (2):487-498.
38. Goldstein, R. Z., and Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12 (11):652-669.
39. González, J. A., Jensen, L., Fugger, L., and Burdakov, D. (2012). Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. European journal of neuroscience 35 (9):1426-1432.
40. Gozzi, A., Turrini, G., Piccoli, L., Massagrande, M., Amantini, D., Antolini, M., Martinelli, P., Cesari, N., Montanari, D., Tessari, M., Corsi, M., and Bifone, A. (2011). Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS One 6 (1):e16406.
41. Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., Munton, R. P., Ashmeade, T. E., Shah, A. S., Hatcher, J. P., Hatcher, P. D., Jones, D. N., Smith, M. I., Piper, D. C., Hunter, A. J., Porter, R. A., and Upton, N. (1999). Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 96 (19):10911-10916.
42. Hamlin, A. S., Newby, J., and Mcnally, G. P. (2007). The neural correlates and role of D1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience 146 (2):525-536.
43. Harris, G. C., Wimmer, M., and Aston-Jones, G. (2005). A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (7058):556-559.
44. Harris, G. C., and Aston-Jones, G. (2006). Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29 (10):571-577.
45. Hoch, M., Hay, J., Hoever, P., De Kam, M., Te Beek, E., Van Gerven, J. M. A., and Dingemanse, J. (2012). Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans. European neuropsychopharmacology.
46. Holtz, N. A., Zlebnik, N. E., and Carroll, M. E. (2012). Differential orexin/hypocretin expression in addiction-prone and-resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake. Neurosci Lett.
47. Horvath, T. L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T. S., and Van Den Pol, A. N. (1999). Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol 415 (2):145-159.
48. James, M. H., Charnley, J. L., Levi, E. M., Jones, E., Yeoh, J. W., Smith, D. W., and Dayas, C. V. (2011). Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 14 (5):684-690.
49. Jaszberenyi, M., Bujdoso, E., Pataki, I., and Telegdy, G. (2000). Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 12 (12):1174-1178.
50. Jia, X., Yan, J., Xia, J., Xiong, J., Wang, T., Chen, Y., Qi, A., Yang, N., Fan, S., Ye, J., and Hu, Z. (2011). Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats. Neuropharmacology.
51. Jupp, B., Krivdic, B., Krstew, E., and Lawrence, A. J. (2011). The orexin receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 1391:54-59.
52. Jupp, B., Krstew, E., Dezsi, G., and Lawrence, A. J. (2011). Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin receptors. Br J Pharmacol 162 (4):880-889.
53. Kalivas, P. W., and Volkow, N. D. (2005). The Neural Basis of Addiction: A Pathology of Motivation and Choice. Am J Psychiatry 162 (8):1403-1413.
54. Karatayev, O., Baylan, J., Weed, V., Chang, S., Wynick, D., and Leibowitz, S. F. (2010). Galanin knockout mice show disturbances in ethanol consumption and expression of hypothalamic peptides that stimulate ethanol intake. Alcohol Clin Exp Res 34 (1):72-80.
55. Korotkova, T. M., Sergeeva, O. A., Eriksson, K. S., Haas, H. L., and Brown, R. E. (2003). Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23 (1):7-11.
56. Kotagale, N. R., Taksande, B. G., Gahane, A. Y., Ugale, R. R., and Chopde, C. T. (2010). Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by alpha2-adrenoceptors. Behav Brain Res 213 (2):161-174.
57. Kuru, M., Ueta, Y., Serino, R., Nakazato, M., Yamamoto, Y., Shibuya, I., and Yamashita, H. (2000). Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11 (9):1977-1980.
58. Langmead, C. J., Jerman, J. C., Brough, S. J., Scott, C., Porter, R. A., and Herdon, H. J. (2004). Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 141 (2):340-346.
59. Lawrence, A. J., Cowen, M. S., Yang, H. J., Chen, F., and Oldfield, B. (2006). The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148 (6):752-759.
60. Lawrence, A. J. (2010). Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 1314:124-129.
61. Lovinger, D. M., White, G., and Weight, F. F. (1989). Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243 (4899):1721-1724.
62. Lovinger, D. M. (1999). 5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic. Neurochem Int 35 (2):125-130.
63. Malherbe, P., Borroni, E., Gobbi, L., Knust, H., Nettekoven, M., Pinard, E., Roche, O., Rogers-Evans, M., Wettstein, J. G., and Moreau, J. L. (2009). Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor. Br J Pharmacol 156 (8):1326-1341.
64. Malherbe, P., Borroni, E., Pinard, E., Wettstein, J. G., and Knoflach, F. (2009). Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists. Mol Pharmacol 76 (3):618-631.
65. Marchant, N. J., Hamlin, A. S., and Mcnally, G. P. (2009). Lateral hypothalamus is required for context-induced reinstatement of extinguished reward seeking. J Neurosci 29 (5):1331-1342.
66. Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., and Weiss, F. (2010). Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 1314:145-161.
67. Martin-Fardon, R., and Weiss, F.(2012). N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea(SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking. Addiction biology.
68. Mcatee, L. C., Sutton, S. W., Rudolph, D. A., Li, X., Aluisio, L. E., Phuong, V. K., Dvorak, C. A., Lovenberg, T. W., Carruthers, N. I., and Jones, T. K. (2004). Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists. Bioorg Med Chem Lett 14 (16):4225-4229.
69. Mcpherson, C. S., Featherby, T., Krstew, E., and Lawrence, A. J. (2007). Quantification of phosphorylated cAMP-response element-binding protein expression throughout the brain of amphetamine-sensitized rats: activation of hypothalamic orexin A-containing neurons. J Pharmacol Exp Ther 323 (3):805-812.
70. Mihic, S. J. (1999). Acute effects of ethanol on GABAA and glycine receptor function. Neurochem Int 35 (2):115-123.
71. Millan, E. Z., Furlong, T. M., and Mcnally, G. P. (2010). Accumbens shell-hypothalamus interactions mediate extinction of alcohol seeking. J Neurosci 30 (13):4626-4635.
72. Moorman, D. E., and Aston-Jones, G. (2009). Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol--preferring Sprague--Dawley rats. Alcohol 43 (5):379-386.
73. Morganstern, I., Chang, G. Q., Barson, J. R., Ye, Z., Karatayev, O., and Leibowitz, S. F. (2010). Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res 34 (5):886-896.
74. Nambu, T., Sakurai, T., Mizukami, K., Hosoya, Y., Yanagisawa, M., and Goto, K. (1999). Distribution of orexin neurons in the adult rat brain. Brain Res 827 (1-2):243-260.
75. Narahashi, T., Aistrup, G. L., Marszalec, W., and Nagata, K. (1999). Neuronal nicotinic acetylcholine receptors: a new target site of ethanol. Neurochem Int 35 (2):131-141.
76. Narita, M., Nagumo, Y., Hashimoto, S., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., and Suzuki, T. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26 (2):398-405.
77. Peyron, C., Tighe, D. K., Van Den Pol, A. N., De Lecea, L., Heller, H. C., Sutcliffe, J. G., and Kilduff, T. S. (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18 (23):9996-10015.
78. Plaza-Zabala, A., Martin-Garcia, E., De Lecea, L., Maldonado, R., and Berrendero, F. (2010). Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 30 (6):2300-2310.
79. Plaza-Zabala, A., Flores, A., Maldonado, R., and Berrendero, F. (2012). Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 71 (3):214-223.
80. Richards, J. K., Simms, J. A., Steensland, P., Taha, S. A., Borgland, S. L., Bonci, A., and Bartlett, S. E. (2008). Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199 (1):109-117.
81. Richardson, K. A., and Aston-Jones, G. (2012). Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J Neurosci 32 (11):3809-3817.
82. Robinson, T. E., and Berridge, K. C. (2008). Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363 (1507):3137-3146.
83. Rodgers, R. J., Halford, J. C., Nunes De Souza, R. L., Canto De Souza, A. L., Piper, D. C., Arch, J. R., Upton, N., Porter, R. A., Johns, A., and Blundell, J. E. (2001). SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13 (7):1444-1452.
84. Rogers, J. L., and See, R. E. (2007). Selective inactivation of the ventral hippocampus attenuates cue-induced and cocaine-primed reinstatement of drug-seeking in rats. Neurobiol Learn Mem 87 (4):688-692.
85. Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., Arch, J. R., Buckingham, R. E., Haynes, A. C., Carr, S. A., Annan, R. S., Mcnulty, D. E., Liu, W. S., Terrett, J. A., Elshourbagy, N. A., Bergsma, D. J., and Yanagisawa, M. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (4):573-585.
86. Sartor, G. C., and Aston-Jones, G. S. (2012). A septal-hypothalamic pathway drives orexin neurons, which is necessary for conditioned cocaine preference. J Neurosci 32 (13):4623-4631.
87. Scammell, T. E., and Winrow, C. J. (2011). Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 51:243-266.
88. Schneider, E. R., Rada, P., Darby, R. D., Leibowitz, S. F., and Hoebel, B. G. (2007). Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcohol Clin Exp Res 31 (11):1858-1865.
89. See, R. E. (2005). Neural substrates of cocaine-cue associations that trigger relapse. Eur J Pharmacol 526 (1-3):140-146.
90. Sharf, R., Guarnieri, D. J., Taylor, J. R., and Dileone, R. J. (2010). Orexin mediates morphine place preference, but not morphine-induced hyperactivity or sensitization. Brain Res 1317:24-32.
91. Shoblock, J. R., Welty, N., Aluisio, L., Fraser, I., Motley, S. T., Morton, K., Palmer, J., Bonaventure, P., Carruthers, N. I., Lovenberg, T. W., Boggs, J., and Galici, R. (2011). Selective blockade of the orexin-2 receptor attenuates ethanol selfadministration, place preference, and reinstatement. Psychopharmacology (Berl) 215 (1):191-203.
92. Smart, D., Sabido-David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., and Jerman, J. C. (2001). SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 132 (6):1179-1182.
93. Smith, R. J., See, R. E., and Aston-Jones, G. (2009). Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 30 (3):493-503.
94. Smith, R. J., Tahsili-Fahadan, P., and Aston-Jones, G. (2010). Orexin/hypocretin is necessary for context-driven cocaine-seeking. Neuropharmacology 58 (1):179-184.
95. Smith, R. J., and Aston-Jones, G. (2012). Orexin/hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 35 (5):798-804.
96. Stanley, B. G., Willett, V. L., 3rd, Donias, H. W., Dee, M. G., 2nd, and Duva, M. A. (1996). Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control. Am J Physiol 270 (2 Pt 2):R443-449.
97. Steiner, M. A., Lecourt, H., Strasser, D. S., Brisbare-Roch, C., and Jenck, F. (2011). Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-alpha1 receptor modulator zolpidem, alone or combined with ethanol, on motor performance in the rat. Neuropsychopharmacology 36 (4):848-856.
98. Stettner, G. M., Kubin, L., and Volgin, D. V. (2011). Antagonism of orexin 1 receptors eliminates motor hyperactivity and improves homing response acquisition in juvenile rats exposed to alcohol during early postnatal period. Behav Brain Res 221 (1):324-328.
99. Stretch, R., Gerber, G. J., and Wood, S. M. (1971). Factors affecting behavior maintained by response-contingent intravenous infusions of amphetamine in squirrel monkeys. Can J Physiol Pharmacol 49 (6):581-589.
100. Van Den Pol, A. N. (1999). Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 19 (8):3171-3182.
101. Vittoz, N., Schmeichel, B., and Berridge, C. (2008). Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons. European journal of neuroscience 28 (8):1629-1640.
102. Volkow, N. D., Fowler, J. S., and Wang, G. J. (2002). Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. Behavioural pharmacology 13 (5-6):355-366.
103. Von Der Goltz, C., Koopmann, A., Dinter, C., Richter, A., Grosshans, M., Fink, T., Wiedemann, K., and Kiefer, F. (2011). Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Hormones and behavior 60 (5):644-650.
104. Voorhees, C. M., and Cunningham, C. L. (2011). Involvement of the orexin/hypocretin system in ethanol conditioned place preference. Psychopharmacology (Berl) 214 (4):805-818.
105. W.H.O. 2011. Global status report on alcohol and health. edited by Organization, W. H. Geneva: WHO Library Cataloguing-in-Publication Data.
106. Wang, B., You, Z. B., and Wise, R. A. (2009). Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 65 (10):857-862.
107. Whitman, D. B., Cox, C. D., Breslin, M. J., Brashear, K. M., Schreier, J. D., Bogusky, M. J., Bednar, R. A., Lemaire, W., Bruno, J. G., Hartman, G. D., Reiss, D. R., Harrell, C. M., Kraus, R. L., Li, Y., Garson, S. L., Doran, S. M., Prueksaritanont, T., Li, C., Winrow, C. J., Koblan, K. S., Renger, J. J., and Coleman, P. J. (2009). Discovery of a potent, CNS-penetrant orexin receptor antagonist based on an n,n-disubstituted-1,4-diazepane scaffold that promotes sleep in rats. ChemMedChem 4 (7):1069-1074.
108. Winrow, C. J., Tanis, K. Q., Reiss, D. R., Rigby, A. M., Uslaner, J. M., Uebele, V. N., Doran, S. M., Fox, S. V., Garson, S. L., Gotter, A. L., Levine, D. M., Roecker, A. J., Coleman, P. J., Koblan, K. S., and Renger, J. J. (2010). Orexin receptor antagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacology 58 (1):185-194.
109. Wise, R. A. (1996). Neurobiology of addiction. Curr Opin Neurobiol 6 (2):243-251.
110. Zhou, L., Ghee, S. M., Chan, C., Lin, L., Cameron, M. D., Kenny, P. J., and See, R. E. (2012). Orexin-1 receptor mediation of cocaine seeking in male and female rats. J Pharmacol Exp Ther 340 (3):801-809.
111. Zhu, Y., Miwa, Y., Yamanaka, A., Yada, T., Shibahara, M., Abe, Y., Sakurai, T., and Goto, K. (2003). Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive G-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and-insensitive G-proteins. J Pharmacol Sci 92 (3):259-266.